BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15923408)

  • 1. Adjuvant chemotherapy of gastric cancer: which regimens?
    De Vita F; Orditura M; Ciardiello F; Catalano G
    Ann Oncol; 2005 May; 16 Suppl 4():iv102-105. PubMed ID: 15923408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neo-adjuvant and adjuvant chemotherapy of gastric cancer.
    De Vita F; Giuliani F; Galizia G; Belli C; Aurilio G; Santabarbara G; Ciardiello F; Catalano G; Orditura M
    Ann Oncol; 2007 Jun; 18 Suppl 6():vi120-3. PubMed ID: 17591804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives in adjuvant therapy of gastric cancer.
    De Vita F; Vecchione L; Galizia G; Di Martino N; Fabozzi T; Catalano G; Ciardiello F; Orditura M
    Oncology; 2009; 77 Suppl 1():38-42. PubMed ID: 20130430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future strategies and adjuvant treatment of gastric cancer.
    Falcone A
    Ann Oncol; 2003; 14 Suppl 2():ii45-7. PubMed ID: 12810458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant (cisplatin, etoposide, and 5-fluorouracil) chemotherapy after curative resection of gastric adenocarcinomas involving the esophagogastric junction.
    Ryoo BY; Kang YK; Im YH; Kim YJ; Kim BS; Kim TY; Jung SH; Park JH; Baek HJ; Kim YC; Shim YM; Kim CM; Zo JI
    Am J Clin Oncol; 1999 Jun; 22(3):253-7. PubMed ID: 10362331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy for gastric carcinoma: closing out the century.
    Yao JC; Shimada K; Ajani JA
    Oncology (Williston Park); 1999 Nov; 13(11):1485-94; discussion 1497-502 passim. PubMed ID: 10581599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of adjuvant chemotherapy for gastric cancer.
    Nakajima T
    World J Surg; 1995; 19(4):570-4. PubMed ID: 7676702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer.
    Takahari D; Hamaguchi T; Yoshimura K; Katai H; Ito S; Fuse N; Kinoshita T; Yasui H; Terashima M; Goto M; Tanigawa N; Shirao K; Sano T; Sasako M
    Cancer Chemother Pharmacol; 2011 Jun; 67(6):1423-8. PubMed ID: 20809123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy.
    Yu W
    Eur J Surg Oncol; 2006 Aug; 32(6):655-60. PubMed ID: 16618532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant and preoperative chemotherapy for gastric cancer.
    Yao JC; Ajani JA
    Curr Oncol Rep; 2002 May; 4(3):222-8. PubMed ID: 11937012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial.
    Nishikawa K; Tsuburaya A; Yoshikawa T; Takahashi M; Tanabe K; Yamaguchi K; Yoshino S; Namikawa T; Aoyama T; Rino Y; Kawada J; Tsuji A; Taira K; Kimura Y; Kodera Y; Hirashima Y; Yabusaki H; Hirabayashi N; Fujitani K; Miyashita Y; Morita S; Sakamoto J
    Gastric Cancer; 2018 Sep; 21(5):811-818. PubMed ID: 29488122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.
    Choi YH; Oh SC; Kim JS; Nam SH; Kim BS; Cho SH; Chung IJ; Song EK; Yim CY; Baek JH; Jeung HC; Hong YS; Yang SH; Kang HJ
    Cancer Chemother Pharmacol; 2012 Nov; 70(5):665-72. PubMed ID: 22926638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy of gastric cancer].
    Konishi T; Teruya M; Kawahara M; Itoh A; Asakura R; Araki S; Hojo K; Nouchi T; Takeda Y
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):504-15. PubMed ID: 9530356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stomach carcinoma. Optimizing therapy by neoadjuvant or adjuvant therapy?].
    Rosen H
    Zentralbl Chir; 1999; 124(5):387-93. PubMed ID: 10420523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination 5-fluoruracil/cisplatinum versus 5-fluoruracil/leucovorin adjuvant chemotherapy efficacy for R0 gastric resection in locally invasive gastric cancer.
    Yamada S; Ritchim P; Charkrabandhu T; Jongraksat W
    J Med Assoc Thai; 2012 Dec; 95(12):1517-23. PubMed ID: 23390781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer.
    Atiq OT; Kelsen DP; Shiu MH; Saltz L; Tong W; Niedzwiecki D; Trochanowski B; Lin S; Toomasi F; Brennan M
    J Clin Oncol; 1993 Mar; 11(3):425-33. PubMed ID: 8445416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.
    Hermans J; Bonenkamp JJ; Boon MC; Bunt AM; Ohyama S; Sasako M; Van de Velde CJ
    J Clin Oncol; 1993 Aug; 11(8):1441-7. PubMed ID: 8336183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of precautionary chemotherapy in gastric cancer].
    Rimassa L; Campagnoli E; Biancofiore G
    Tumori; 2000; 86(5 Suppl 2):S5-13. PubMed ID: 11195303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative adjunctive treatment in the management of operable gastric cancer.
    Silberman H
    J Surg Oncol; 2005 Jun; 90(3):174-86; discussion 186-7. PubMed ID: 15895444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.